Quest Diagnostics Incorporated

Quest Diagnostics' headline numbers in this dataset are straightforward: revenue reached $11.04 billion in 2025 and operating income was $1.56 billion. What the data cannot show is why. No MD&A text is on file, so this synthesis cannot name the testing categories, segments, acquisitions, or payer dynamics that management credits for the change, and it cannot check whether management's own narrative agrees with the numbers. Likewise, no risk-factor text, legal proceedings, debt instruments, or regulatory disclosures are on file, so no litigation or regulatory exposure is discussed here. No forensic scores are on file for DGX, so no Beneish M-Score, Piotroski F-Score, Altman Z-Score, or Fog Index value is given. That absence is itself a limit: this page cannot be used to screen for accounting-quality flags, and a clean-looking revenue line is not a substitute for that screen. The arithmetic available is limited. Revenue grew about 11.9% in 2025 after about 6.7% growth in 2024, and both years followed a decline in 2022 and 2023. Operating income of $1.56 billion equals about 14.1% of 2025 revenue, but only one year of operating income is provided, so no margin trend can be measured. Readers may want to look at the full Form 10-K, particularly the MD&A, risk factors, segment note, cash flow statement, and the notes on debt and contingencies, to test the company's narrative against these figures. Those sections would show what drove the revenue change, whether cash generation tracks reported operating income, and what management itself flags as uncertain.

Catalyst.The data shows Quest Diagnostics reporting 2025 revenues of $11.04 billion, up from $9.87 billion in 2024, an increase of roughly 11.9%. That followed a 2024 gain of about 6.7% over 2023's $9.25 billion. Operating income for 2025 was $1.56 billion, roughly 14.1% of revenue. The MD&A text needed to explain which segments, products, or programs produced this growth is not on file, so this synthesis cannot attribute the increase to any specific driver.

Hidden risk.The most important tension here is one a casual reader could miss: revenue has not followed a steady upward path. Annual revenue peaked at $10.79 billion in 2021, then fell to $9.88 billion in 2022 and $9.25 billion in 2023 before recovering. A year or two of growth after a multi-year decline does not by itself show the earlier pressures have ended. Risk-factor text is not on file, so this synthesis cannot say which pressures management itself identifies. Readers may want to look at the risk-factor section of the Form 10-K for that.